Product Name :
EFdA-TP
Description:
EFdA-TP is a potent nucleoside reverse transcriptase (RT) inhibitor. EFdA-TP inhibits RT-catalyzed DNA synthesis as an effective immediate or delayed chain terminator (ICT or DCT). EFdA-TP inhibits HIV-1 RT with multiple mechanisms.
CAS:
950913-56-1
Molecular Weight:
533.19
Formula:
C12H15FN5O12P3
Chemical Name:
([([(2R, 3S, 5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl)oxy](hydroxy)phosphoryloxy)phosphonic acid
Smiles :
C#C[C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H](C[C@@H]1O)N1C=NC2=C(N)N=C(F)N=C12
InChiKey:
BUMPFXRZUYYODO-QRPMWFLTSA-N
InChi :
InChI=1S/C12H15FN5O12P3/c1-2-12(4-27-32(23,24)30-33(25,26)29-31(20,21)22)6(19)3-7(28-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19H,3-4H2,(H,23,24)(H,25,26)(H2,14,16,17)(H2,20,21,22)/t6-,7+,12+/m0/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
EFdA-TP is a potent nucleoside reverse transcriptase (RT) inhibitor. EFdA-TP inhibits RT-catalyzed DNA synthesis as an effective immediate or delayed chain terminator (ICT or DCT).Liarozole Inhibitor EFdA-TP inhibits HIV-1 RT with multiple mechanisms.SR9011 MedChemExpress |Product information|CAS Number: 950913-56-1|Molecular Weight: 533.19|Formula: C12H15FN5O12P3|Chemical Name: ([([(2R, 3S, 5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl)oxy](hydroxy)phosphoryloxy)phosphonic acid|Smiles: C#C[C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H](C[C@@H]1O)N1C=NC2=C(N)N=C(F)N=C12|InChiKey: BUMPFXRZUYYODO-QRPMWFLTSA-N|InChi: InChI=1S/C12H15FN5O12P3/c1-2-12(4-27-32(23,24)30-33(25,26)29-31(20,21)22)6(19)3-7(28-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19H,3-4H2,(H,23,24)(H,25,26)(H2,14,16,17)(H2,20,21,22)/t6-,7+,12+/m0/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.PMID:32496945 |Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|EFdA-TP (0.05-10 μM; for 15 min) inhibits RT-catalyzed DNA synthesis as an ICT or DCT. EFdA-TP can block RT as a translocation-defective RT inhibitor that dramatically slows DNA synthesis, acting as a de facto immediate chain terminator. EFdA-TP can function as a delayed chain terminator, allowing incorporation of an additional dNTP before blocking DNA synthesis.|Products are for research use only. Not for human use.|